INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 June 2011
Total net assets |
£101.3m |
NAV per share |
180.8p |
Share price |
153.5p |
Total value of unquoted investments |
£25.4m |
Total number of portfolio companies |
63 |
Cash |
1% NAV |
Cash committed and reserved to unquoted investments |
10% NAV |
Portfolio companies with < 1 year of cash |
12% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
5.81 |
Cadent |
5.60 |
Teva |
5.57 |
Insulet |
4.91 |
Gilead Sciences |
4.56 |
Celgene |
4.19 |
Shire |
4.19 |
Micromet |
3.80 |
Pharmasset |
3.70 |
Aptiv |
2.77 |
|
----------- |
Total |
45.10 |
Geographical Allocation |
% |
United States |
72 |
Europe |
20 |
Israel |
6 |
Australia |
1 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
74 |
Unquoted |
25 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 JULY 2011